Abbott Laboratories (ABT)

104.75
1.20 1.10
NYSE
Prev Close 105.95
Open 105.46
Day Low/High 103.56 / 105.52
52 Wk Low/High 61.61 / 114.19
Volume 4.18M
Exchange NYSE
Shares Outstanding 1770.53B
Market Cap 189.20B
P/E Ratio 61.77
Div & Yield N.A. (N.A)

Latest News

Charting the Best Hotels in the Sector

Charting the Best Hotels in the Sector

We grade Choice Hotels, Hilton and Marriott, and check on the opportunities each offers.

Rapid Test, Rapid Dow Rally?

Rapid Test, Rapid Dow Rally?

Here's what I expect to happen to the market near term off this potentially game-changing development.

Jim Cramer: Abbott Labs and the Rally in Travel

Jim Cramer: Abbott Labs and the Rally in Travel

ABT will end the issues of flying and cruising. Of course it's another story when you get there. But boarding will be solved.

If You Like Laggards, Here Are 3 to Consider

If You Like Laggards, Here Are 3 to Consider

These companies will benefit immensely as the country experiences a burst of economic growth.

Market Continues Higher in Front of Big Stock Splits and Dow Rebalancing

Market Continues Higher in Front of Big Stock Splits and Dow Rebalancing

There is major rotational action taking place but the flood of liquidity is preventing any real downside from developing.

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Vaccine Chills, Divergent Trails, Fed-flation, Walmart and TikTok: Market Recon

Plus, Veeva Systems reports stellar results and ups its guidance.

Rotation Unravels Speculative Plays

Rotation Unravels Speculative Plays

Speculative trading in lower-priced stocks has dried up and the small caps have been much tougher.

Jim Cramer: Here Comes the Biggest Test Yet

Jim Cramer: Here Comes the Biggest Test Yet

As the president pins all hopes on a Covid vaccine and shuns tried-and-true prevention efforts, Abbott is offering a rapid test that could be a game changer.

There Are Several Different Market Themes Now

There Are Several Different Market Themes Now

One is Abbott Labs' announcement of a quick and cheap Covid test.

Abbott Labs Soars to New Heights: The Stock's Next Technical Targets

Abbott Labs Soars to New Heights: The Stock's Next Technical Targets

Here's where ABT could be headed next.

Focus on Rotation and Not the Direction of the Indices

Focus on Rotation and Not the Direction of the Indices

It isn't just valuation that is likely to drive rotational action.

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Jim Cramer: All These Stocks Are Not Quite 'Dow and Out'

Let's look at the Dow Jones' swapping of Exxon for Salesforce, Pfizer for Amgen and Raytheon for Honeywell.

Jim Cramer: 'Excuse Selling'

Jim Cramer: 'Excuse Selling'

Let's go over five excuses so you know and are armed with them when they are used and make you faint and weak-handed.

Jim Cramer: An Analyst's Dream

Jim Cramer: An Analyst's Dream

All we have to do is take our cue from companies that boosted their forecasts but their stocks did nothing.

We'll Be Checking on These Corporate Earnings Next Week

Next week the June quarter earnings season maelstrom kicks off with 115 companies, including 32 S&P 500 constituents, reporting their latest quarterly results. In recent days we've seen a number of companies up their outlook for the quarter but we'v...

I Wouldn't Buy Pfizer Shares on This Pop

I Wouldn't Buy Pfizer Shares on This Pop

I would wait until the next down day, and there will be one.

Abbott Cut to Sell at Goldman Sachs

Keeping an Eye on Abbott Labs Stock

Keeping an Eye on Abbott Labs Stock

The current quarter, according to the analyst community, is understandably not shaping up as stellar.

The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance

The Reasons to Be in AbbVie: Valuation, Dividend Yield, Confidence in Guidance

I have always liked the aggressive management.

Are You a Trader, Investor, or Opportunist?

Are You a Trader, Investor, or Opportunist?

Don't pigeon hole yourself into a certain pattern of action when you see opportunities.

Want to Know Why I'm Not Selling Moderna?

Want to Know Why I'm Not Selling Moderna?

I'm staying long this name, and I'm staying long PFE and JNJ, and I'm staying long GILD and ABT. You know why? Because I'm optimistic.

CVS Health Reports and Here's How I'd Play It

CVS Health Reports and Here's How I'd Play It

CVS Health states that the chain has kept its stores open as an 'essential' retailer through this pandemic.

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Jim Cramer: Oil Tanked, and We're in Uncharted Waters

Oil isn't really worthless and Amazon isn't the only retailer that will survive, but we are in a mixed up market thanks to Covid-19.

How I See Market Performance Evolving Over Time, Trading Advanced Micro

How I See Market Performance Evolving Over Time, Trading Advanced Micro

Will tech continue to trend toward leadership? Who among us can remember when it has not?

Jim Cramer: How to Stay Safe, Until Quick Testing for Covid-19 Is Available

Jim Cramer: How to Stay Safe, Until Quick Testing for Covid-19 Is Available

Welcome to the new era. Social distancing is not without risks, but it is as good as it gets.

My New Multi-Group Portfolio Strategy for Trading the Pandemic

My New Multi-Group Portfolio Strategy for Trading the Pandemic

How has my book evolved since the Fed and Treasury rode into town? Here's how.

Most of the Strong Stocks Out There Are Beneficiaries of the Coronavirus Crisis

Most of the Strong Stocks Out There Are Beneficiaries of the Coronavirus Crisis

Although there is great fear of the economic issues that lie ahead, there is still a hunger for speculative action in the market.

5 Ways to Invest in Testing, Vaccines and Clinical Trials

5 Ways to Invest in Testing, Vaccines and Clinical Trials

These companies have the potential to help in battling the Covid-19 pandemic.